» Articles » PMID: 18795253

Dexmedetomidine Versus Propofol/midazolam for Long-term Sedation During Mechanical Ventilation

Overview
Specialty Critical Care
Date 2008 Sep 17
PMID 18795253
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare dexmedetomidine (DEX) with standard care (SC, either propofol or midazolam) for long-term sedation in terms of maintaining target sedation and length of intensive care unit (ICU) stay.

Methods: A pilot, phase III, double-blind multicenter study in randomized medical and surgical patients (n = 85) within the first 72 h of ICU stay with an expected ICU stay of >or=48 h and sedation need for >or=24 h after randomization. Patients were assigned to either DEX (<or=1.4 microg kg(-1) h(-1); n = 41) or SC (n = 44), with daily sedation stops.

Results: Non-inferiority of DEX versus SC was not confirmed. Target Richmond agitation-sedation score (RASS) was reached a median of 64% (DEX) and 63% (SC) of the sedation time (ns). The length of ICU stay was similar in DEX and SC. Patients with RASS target 0-3 (DEX 78%, SC 80%) were at target sedation 74% (DEX) and 64% (SC) of the time (ns), whereas those with RASS target -4 or less reached the target 42% (DEX) and 62% (SC) of the time (P = .006). Post hoc analyses suggested shorter duration of mechanical ventilation for DEX (P = 0.025).

Conclusions: This pilot study suggests that in long-term sedation, DEX is comparable to SC in maintaining sedation targets of RASS 0 to -3 but not suitable for deep sedation (RASS -4 or less). DEX had no effect on length of ICU stay. Its effects on other relevant clinical outcomes, such as duration of mechanical ventilation, should be tested further.

Citing Articles

Combining O High Flow Nasal or Non-Invasive Ventilation with Cooperative Sedation to Avoid Intubation in Early Diffuse Severe Respiratory Distress Syndrome, Especially in Immunocompromised or COVID Patients?.

Petitjeans F, Longrois D, Ghignone M, Quintin L J Crit Care Med (Targu Mures). 2025; 10(4):291-315.

PMID: 39916864 PMC: 11799322. DOI: 10.2478/jccm-2024-0035.


A comparation of dexmedetomidine and midazolam for sedation in patients with mechanical ventilation in ICU: A systematic review and meta-analysis.

Wen J, Ding X, Liu C, Jiang W, Xu Y, Wei X PLoS One. 2023; 18(11):e0294292.

PMID: 37963140 PMC: 10645332. DOI: 10.1371/journal.pone.0294292.


Efficacy and Safety of Ciprofol Sedation in ICU Patients Undergoing Mechanical Ventilation: A Multicenter, Single-Blind, Randomized, Noninferiority Trial.

Liu Y, Peng Z, Liu S, Yu X, Zhu D, Zhang L Crit Care Med. 2023; 51(10):1318-1327.

PMID: 37272947 PMC: 10497206. DOI: 10.1097/CCM.0000000000005920.


Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trials.

Lewis K, Alshamsi F, Carayannopoulos K, Granholm A, Piticaru J, Duhailib Z Intensive Care Med. 2022; 48(7):811-840.

PMID: 35648198 DOI: 10.1007/s00134-022-06712-2.


Sequential use of midazolam and dexmedetomidine for long-term sedation may reduce weaning time in selected critically ill, mechanically ventilated patients: a randomized controlled study.

Zhou Y, Yang J, Wang B, Wang P, Wang Z, Yang Y Crit Care. 2022; 26(1):122.

PMID: 35505432 PMC: 9066885. DOI: 10.1186/s13054-022-03967-5.


References
1.
Corbett S, Rebuck J, Greene C, Callas P, Neale B, Healey M . Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Crit Care Med. 2005; 33(5):940-5. DOI: 10.1097/01.ccm.0000162565.18193.e5. View

2.
Ely E, Inouye S, Bernard G, Gordon S, Francis J, May L . Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001; 286(21):2703-10. DOI: 10.1001/jama.286.21.2703. View

3.
Sydow M, Neumann P . Sedation for the critically ill. Intensive Care Med. 1999; 25(6):634-6. DOI: 10.1007/s001340050917. View

4.
Hall J, Uhrich T, BARNEY J, Arain S, Ebert T . Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000; 90(3):699-705. DOI: 10.1097/00000539-200003000-00035. View

5.
Prielipp R, Wall M, Tobin J, Groban L, Cannon M, Fahey F . Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow. Anesth Analg. 2002; 95(4):1052-9, table of contents. DOI: 10.1097/00000539-200210000-00048. View